Contents

Current Pharmaceutical Design, Volume 10 - Number 28

Preface [ Endocrine and Metabolic Agents (Executive Editors: A.S. Wagman and W.L. Cody)]

, 10(28): ii

Allan S. Wagman and Wayne L. Cody


DOI: 10.2174/13816128104080200ii




Progress in the Development of Melanocortin Receptor Selective Ligands

, 10(28): 3443 - 3479

Boman G. Irani, Jerry R. Holder, Aleksandar Todorovic, Andrzej M. Wilczynski, Christine G. Joseph, Krista R. Wilson and Carrie Haskell-Luevano


DOI: 10.2174/1381612043382891




Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and Obesity

, 10(28): 3481 - 3504

Zhonghua Pei, Gang Liu, Thomas H. Lubben and Bruce G. Szczepankiewicz


DOI: 10.2174/1381612043382954




New Pharmacological Perspectives and Therapeutic Potential of PPAR-γ Agonists

, 10(28): 3505 - 3524

C. Alarcon de la Lastra, S. Sanchez-Fidalgo, I. Villegas and V. Motilva


DOI: 10.2174/1381612043382909




Thyroid Hormone Ligands and Metabolic Diseases

, 10(28): 3525 - 3532

Johan Malm


DOI: 10.2174/1381612043382873




Recent Progress in Work on PGD2 Antagonists for Drugs Targeting Allergic Diseases

, 10(28): 3533 - 3538

Susumu Mitsumori


DOI: 10.2174/1381612043382864




Receptor Tyrosine Kinases are Signaling Intermediates of G Protein- Coupled Receptors

, 10(28): 3539 - 3545

A. Piiper and S. Zeuzem


DOI: 10.2174/1381612043382936




Combination Therapy of Inhaled Corticosteroids and Long-Acting β2- Adrenergics In Management of Patients with Chronic Obstructive Pulmonary Disease

, 10(28): 3547 - 3560

Don D. Sin, Malcolm Johnson, Wen Qi Gan and S. F. Paul Man


DOI: 10.2174/1381612043382990




Quaternary Ammonium Derivatives as Spasmolytics for Irritable Bowel Syndrome

, 10(28): 3561 - 3568

S. Evangelista


DOI: 10.2174/1381612043382972




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science